Do you want to read an article? Please log in or register.
Clinical and spirometric variables are better predictors of COPD exacerbations than routine blood biomarkers
COPD
RECOMMENDED
Related content
RECOMMENDED
COPD
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Singh D, Wedzicha JA, Siddiqui S, de la Hoz A, Xue W, Magnussen H, Miravitlles M, Chalmers JD, Calverley PMA
doi: 10.1186/s12931-020-01482-1.
COMMENTED
AsthmaCOPDEmphysema
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort
Lancet Respir Med.
Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, Putcha N, Ortega VE, Li X, Barr RG, Carretta EE, Couper DJ, Cooper CB, Hoffman EA, Kanner RE, Kleerup E, O'Neal WK, Paine R 3rd, Peters SP, Alexis NE, Woodruff PG, Han MK, Meyers DA, Bleecker ER8; SPIROMICS investigators
doi: 10.1016/
RECOMMENDED
Asthma
Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function
Respir Med.
Mansur AH, Srivastava S, Sahal A
doi: 10.1016/j.rmed.2018.08.005.
RECOMMENDED
COPD
Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
Respir Res.
Vogelmeier CF, Kostikas K, Fang J, Tian H, Jones B, Morgan CL, Fogel R, Gutzwiller FS, Cao H
doi: 10.1186/s12931-019-1130-y.
COPD
Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Int J Chron Obstruct Pulmon Dis.
Beeh KM, Beier J, Candler H, Wittig T
doi: 10.2147/COPD.S11765
RECOMMENDED
COPD
Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care
BMC Med.
Bloom CI, Ricciardi F, Smeeth L, Stone P, Quint JK
doi: 10.1186/s12916-019-1310-0.
RECOMMENDED
COPD
COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging
Eur Respir J.
Washko GR, Parraga G
doi: 10.1183/13993003.
COPDRespiratory Tract Infection
The use of cellular and molecular biomarkers to manage COPD exacerbations
Expert Rev Respir Med.
Ho T, Dasgupta A, Hargreave FE, Nair P
doi: 10.1080/17476348.
RECOMMENDED
COPD
COPD Biomarkers and their Interpretation
Am J Respir Crit Care Med.
Stockley RA, Halpin DMG, Celli BR, Singh D
doi: 10.1164/rccm.201810-1860SO.